News

Filter

Current filters:

None

55 to 64 of 96529 results

Age is a factor when looking at diabetes management, Sanofi survey finds

Age is a factor when looking at diabetes management, Sanofi survey finds

15-10-2014

The US subsidiary of French pharma major Sanofi has announced the findings of a new survey that reveals…

DiabetesPharmaceuticalResearchSanofiUSA

Orexigen earns total $100 million milestone on Contrave

Orexigen earns total $100 million milestone on Contrave

15-10-2014

US biopharma company Orexigen Therapeutics says it has earned a $70 million milestone payment from partner…

ContraveFinancialMarkets & MarketingMetabolicsOrexigen TherapeuticsPharmaceuticalTakeda PharmaceuticalUSA

Japan’s Santen sets up its own subsidiary in Italy

Japan’s Santen sets up its own subsidiary in Italy

15-10-2014

Japanese mid-size ophthalmic drugmaker Santen Pharmaceutical says it has established a wholly-owned subsidiary…

CosoptItalyMarkets & MarketingOphthalmicsPharmaceuticalSaflutanSanten Pharmaceuticals

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

15-10-2014

There was good news for Japanese drugmaker Eisai yesterday, as the US Food and Drug Administration granted…

BanzelEisailenvatinibNeurologicalOncologyPharmaceuticalRegulationRufinamide TabletsUSA

Northwest Bio says DCVax-L hospital exemption program under way in Germany

Northwest Bio says DCVax-L hospital exemption program under way in Germany

15-10-2014

US biotech firm Northwest Biotherapeutics, which is developing DCVax personalized immune therapies for…

BiotechnologyDCVax-LGermanyNorthwest BiotherapeuticsOncologyRegulationResearch

Roche signs deal with DKSH to expand access across Asia

Roche signs deal with DKSH to expand access across Asia

15-10-2014

Switzerland-based market expansion services provider DKSH has signed an agreement with Swiss pharma major…

AsiaAsia-PacificDKSHManagementPharmaceuticalRocheRoche Thailand LimitedSwitzerland

Canadian drugmakers’ R&D spending drops to record low

Canadian drugmakers’ R&D spending drops to record low

15-10-2014

Spending by brand-name drug companies on R&D in Canada has dropped to the lowest level ever recorded,…

CanadaFinancialPharmaceuticalResearch

55 to 64 of 96529 results

Parexel

Parexel

Back to top